Pharmacyclics Inc. (PCYC) reported second quarter adjusted EPS of $0.62 after the close Thursday, down from $0.82 in the prior year period. The consensus estimate was for EPS of $0.29.
Pharmacyclics rose steadily during the first half of Friday's session and closed up by 6.79 at $87.00 on above average volume. The stock rose to its third consecutive new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.